Tom Staudt

Related News

  • microscope-slide-research-close-up-60022

    ARK Invest Announces Primary Listing Venue Changes For ARK Genomic Revolution

    ARK Investment Management LLC (ARK or ARK Invest), a New York-based investment adviser focused solely on disruptive innovation in the public equity markets, announced plans to change the primary listing venue of the ARK Genomic Revolution ETF (ARKG) and the ARK Autonomous Technology & Robotics ETF (ARKQ) from the NYSE Arca, Inc. to the Cboe BZX Exchange, Inc. ARK anticipates that ARKG and ARKQ will begin trading on the Cboe BZX Exchange, Inc. under their current ticker symbols on December 31, 2019. No shareholder action is required as a result of this change.
    Read More »
Back to top button